The independent source for health policy research, polling, and news.
1-20 of 482 results
The rapid emergence of the Chinese biotech industry has panicked U.S. politicians, but investors and patients caution that a clampdown on pharmaceutical collaboration could hurt everyone.
Experimental peptides are all the rage on longevity and 鈥渙ptimization鈥 podcasts, but a lot of the chatter is misleading.
People who have taken experimental peptides, such as BPC-157, complain of migraines, eye pain, fatigue, and more. Learning whether these popular but unproven drugs are to blame may become harder if Robert F. Kennedy Jr. fulfills a promise to make them more accessible.
A Slack workspace managed by the Centers for Medicare & Medicaid Services has served as an extraordinary war room for AI industry insiders and Trump administration officials to launch a rapid campaign aimed at persuading Americans to manage their healthcare and medical records on apps.
Recent outbreaks of foodborne illness and high-profile recalls have made this issue a concern of voters.
To get drugs and devices out faster, the FDA lets companies conduct studies of safety or efficacy after the products are approved. In many cases, such 鈥減ostmarket鈥 studies are behind schedule or overdue, records show.
吃瓜不打烊 journalists made the rounds on national and local media recently to discuss topical stories. Here鈥檚 a collection of their appearances.
The agreements, covering issues like drug pricing, reducing the use of synthetic food dyes, and cutting back on insurance prior authorization rules, were announced with fanfare and touted as victories. But it鈥檚 not clear whether they鈥檒l result in lasting change.
Patients and researchers point to evidence that many cancer drug dosages are excessive, and that reducing the amount and frequency could save billions of dollars and prevent some of the worst side effects.
The way people undergo abortions has changed. This video details five things to know.
吃瓜不打烊 journalists made the rounds on national or local media recently to discuss topical stories. Here鈥檚 a collection of their appearances.
The recent outbreak of a foodborne parasite sickened thousands and hospitalized hundreds across the U.S. before federal investigators identified the suspected source. Food safety experts say cuts to the public health system hobbled the response 鈥 and that the next outbreak could be much worse.
California鈥檚 laws still leave extradition decisions related to reproductive rights and gender-affirming care to its governor. But as states with abortion bans target California physicians who prescribe abortion pills across state lines, Democrats want to lock in protections for doctors, no matter who the next governor is.
When makers of infant formula hear that babies got sick or died while using their products, what happens next is left largely to the manufacturers. They decide whether to inform the FDA about possible harm, which could trigger steps to protect the public.
吃瓜不打烊 journalists made the rounds on national media last week to discuss topical stories. Here鈥檚 a collection of their appearances.
As a federal court mulls a case that could result in significant restrictions on a pill used in most abortions, providers say they have alternatives to preserve access even in states with bans in place.
Four years after the Volunteer State enacted the nation鈥檚 first law allowing drugstores to sell ivermectin without patient-specific prescriptions, dozens of pharmacies dispense the drug in highly concentrated pills 鈥 many with the help of one anti-vaccine physician.
The Trump administration has pursued an extensive pro-tobacco agenda as the president and his political movement have been buoyed by a flood of tobacco industry money, federal records show.
The FDA has approved the sunscreen chemical bemotrizinol, a UV light filter that has been available in Europe, Asia, and Australia for more than 20 years. Health advocates and skin care industry groups alike are hopeful it can restore faith in sunscreen.
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded. Meanwhile, researchers and doctors are concerned that some of these online companies aren't properly screening or monitoring patients. 鈥淚t gives a black eye to telemedicine,鈥 one researcher said.
漏 2026 KFF